BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32206630)

  • 1. Successful Treatment with Rituximab and Immunoadsorption for an Auto-Antibody Induced Bile Salt Export Pump Deficiency in a Liver Transplanted Patient.
    Quintero J; Juamperez J; Gonzales E; Julio E; Mercadal-Hally M; Collado-Hilly M; Marín-Sánchez A; Charco R
    Pediatr Gastroenterol Hepatol Nutr; 2020 Mar; 23(2):174-179. PubMed ID: 32206630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.
    Prusinskas B; Kathemann S; Pilic D; Hegen B; Küster P; Keitel V; Häussinger D; Büscher R; Baba HA; Hoyer PF; Lainka E
    Transplant Proc; 2017 Sep; 49(7):1628-1633. PubMed ID: 28838453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency.
    Stindt J; Dröge C; Lainka E; Kathemann S; Pfister ED; Baumann U; Stalke A; Grabhorn E; Shagrani MA; Mozer-Glassberg Y; Hartley J; Wammers M; Klindt C; Philippski P; Liebe R; Herebian D; Mayatepek E; Berg T; Schmidt-Choudhury A; Wiek C; Hanenberg H; Luedde T; Keitel V
    JHEP Rep; 2023 Jul; 5(7):100690. PubMed ID: 37425215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
    Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcomes after liver transplantation for progressive familial intrahepatic cholestasis: A systematic review and meta-analysis.
    Kavallar AM; Mayerhofer C; Aldrian D; Okamoto T; Müller T; Vogel GF
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloimmunity and Cholestasis After Liver Transplantation in Children With Progressive Familial Intrahepatic Cholestasis.
    Krebs-Schmitt D; Briem-Richter A; Brinkert F; Keitel V; Pukite I; Lenhartz H; Fischer L; Grabhorn E
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):169-174. PubMed ID: 30664572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
    Wischlen E; Laverdure N; Erard D; Rohmer B; Boillot O; Dubois R; Lachaux A; Collardeau-Frachon S; Hervieu V; Dumortier J
    Clin Res Hepatol Gastroenterol; 2023 May; 47(6):102139. PubMed ID: 37187258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
    Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
    World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of Progressive Familial Intrahepatic Cholestasis Type 2 Phenotype After Living-donor Liver Transplantation: A Case Report.
    Masahata K; Uehara S; Ibuka S; Nakahata K; Hasegawa Y; Kondou H; Kubitz R; Ueno T
    Transplant Proc; 2016 Nov; 48(9):3156-3162. PubMed ID: 27932171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation.
    Lin HC; Alvarez L; Laroche G; Melin-Aldana H; Pfeifer K; Schwarz K; Whitington PF; Alonso EM; Ekong UD
    Liver Transpl; 2013 Dec; 19(12):1403-10. PubMed ID: 24115678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transplant Recurrent Bile Salt Export Pump Disease: A Form of Antibody-mediated Graft Dysfunction and Utilization of C4d.
    Patel KR; Harpavat S; Finegold M; Eldin K; Hicks J; Firan M; Keitel V; Kubitz R; Wu H
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):364-369. PubMed ID: 28945205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes after cholecystocolostomy for progressive familial intrahepatic cholestasis.
    Chen L; Xiao H; Ren XH; Li L
    Hepatol Res; 2018 Dec; 48(13):1163-1171. PubMed ID: 29934967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Use of Bortezomib for Recurrent Progressive Familial Intrahepatic Cholestasis Type II After Liver Transplantation: A Pediatric Case with a 9-Year Follow-Up.
    Bak YG; Choi HJ; Kim YE; Oh SH; Kim KM
    Pediatr Gastroenterol Hepatol Nutr; 2024 Jan; 27(1):71-76. PubMed ID: 38249643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic haematopoietic stem cell transplantation eliminates alloreactive inhibitory antibodies after liver transplantation for bile salt export pump deficiency.
    Brinkert F; Pukite I; Krebs-Schmitt D; Briem-Richter A; Stindt J; Häussinger D; Keitel V; Müller I; Grabhorn E
    J Hepatol; 2018 Oct; 69(4):961-965. PubMed ID: 29935200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease).
    Siebold L; Dick AA; Thompson R; Maggiore G; Jacquemin E; Jaffe R; Strautnieks S; Grammatikopoulos T; Horslen S; Whitington PF; Shneider BL
    Liver Transpl; 2010 Jul; 16(7):856-63. PubMed ID: 20583290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series.
    Masahata K; Ueno T; Bessho K; Kodama T; Tsukada R; Saka R; Tazuke Y; Miyagawa S; Okuyama H
    Surg Case Rep; 2022 Jan; 8(1):10. PubMed ID: 35024979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive Familial Intrahepatic Cholestasis (PFIC) in Indian Children: Clinical Spectrum and Outcome.
    Agarwal S; Lal BB; Rawat D; Rastogi A; Bharathy KG; Alam S
    J Clin Exp Hepatol; 2016 Sep; 6(3):203-208. PubMed ID: 27746616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive familial intrahepatic cholestasis.
    Srivastava A
    J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.
    Bull LN; Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Dodge JL; Emerick K; Wanty C; Wali S; Blanchard S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Houwen R; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Sokal E; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ
    Hepatol Commun; 2018 May; 2(5):515-528. PubMed ID: 29761168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
    Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.